Literature DB >> 9697817

Homocysteine, vitamins, and cardiovascular disease.

L H Kuller, R W Evans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9697817     DOI： 10.1161/01.cir.98.3.196

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

Review 1.  [Angiology update].

Authors:  C Ranke; H J Trappe
Journal:  Med Klin (Munich)       Date:  1999-05-15

2.  Hyperhomocyst(e)inemia.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-02

Review 3.  Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.

Authors:  Brahmajee K Nallamothu; A Mark Fendrick; Gilbert S Omenn
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

4.  Hyperhomocysteinemia in patients with Behçet's disease: is it due to inflammation or therapy?

Authors:  Zeki Yesilova; Salih Pay; Cagatay Oktenli; Ugur Musabak; Kenan Saglam; S Yavuz Sanisoglu; Kemal Dagalp; M Kemal Erbil; Ismail H Kocar
Journal:  Rheumatol Int       Date:  2004-04-01       Impact factor: 2.631

Review 5.  Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.

Authors:  D A Stehouwer
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

Review 6.  Homocysteine and atherothrombosis.

Authors:  E Falk; J Zhou; J Møller
Journal:  Lipids       Date:  2001       Impact factor: 1.880

7.  Syndrome X.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.